Viewing Study NCT00257179



Ignite Creation Date: 2024-05-05 @ 12:09 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00257179
Status: UNKNOWN
Last Update Posted: 2006-03-14
First Post: 2005-11-21

Brief Title: The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor
Sponsor: National Taiwan University Hospital
Organization: National Taiwan University Hospital

Study Overview

Official Title: None
Status: UNKNOWN
Status Verified Date: 2005-06
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study uses serum tissue factor and tissue factor inhibitor and factor VII to monitor the pre-coagulation status in lung cancer patients and to correlate the pre-coagulation status with clinical staging and prognosis
Detailed Description: The staging of lung cancer was according to tumor size involvement of lymph node and metastatic status But there is a different prognosis in cancer patients of the same stage The coagulation status of cancer patients was considered as an important possible prognostic factor So in this study we want to evaluate patients coagulation status and find the relation of coagulation status and cancer status

We thus propose a prospective study using coagulation factors in order to search for the relationship between cancer stage and pre-coagulation status in Taiwanese lung cancer patients We will also evaluate the potential use of tissue factor as a prognosis predictor in lung cancer patients

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None